MwanzoMLLCF • OTCMKTS
add
Molecular Partners AG
Bei iliyotangulia
$ 4.53
Bei za mwaka
$ 3.66 - $ 10.14
Thamani ya kampuni katika soko
239.77M USD
Wastani wa hisa zilizouzwa
28.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
SWX
Habari za soko
TipRanks
saa 9 zilizopita
Microsoft (NASDAQ:MSFT) Stock: Turn the Dip into a Golden Buying Opportunity
1.17%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CHF) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 681.00 | -73.20% |
Matumizi ya uendeshaji wa biashara | 4.41M | -0.38% |
Mapato halisi | -16.40M | -43.40% |
Kiwango cha faida halisi | elfu -2.41 | -435.08% |
Mapato kwa kila hisa | -0.49 | — |
EBITDA | -14.00M | -8.64% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CHF) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 143.62M | -30.49% |
Jumla ya mali | 154.21M | -29.30% |
Jumla ya dhima | 15.43M | -29.56% |
Jumla ya hisa | 138.78M | — |
hisa zilizosalia | 33.19M | — |
Uwiano wa bei na thamani | 1.08 | — |
Faida inayotokana na mali | -22.46% | — |
Faida inayotokana mtaji | -24.30% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CHF) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -16.40M | -43.40% |
Pesa kutokana na shughuli | -13.28M | -0.68% |
Pesa kutokana na uwekezaji | 14.22M | -20.00% |
Pesa kutokana na ufadhili | elfu -301.00 | -1.01% |
Mabadiliko halisi ya pesa taslimu | elfu 66.00 | -98.72% |
Mtiririko huru wa pesa | -8.09M | -4.19% |
Kuhusu
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
Ilianzishwa
2004
Tovuti
Wafanyakazi
162
